PHARMACOGENOMICS: INDIVIDUALIZED DRUG SELECTION

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/2525

Full metadata record

DC Field	Value	Language
dc.contributor.author	Qayumova Dinara, Salohiddinova Sevinch., N.A. Abzalova	-
dc.date.accessioned	2025-12-07T07:19:45Z	-
dc.date.available	2025-12-07T07:19:45Z	-
dc.date.issued	2025	-
dc.identifier.issn	2181-4341	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/2525	-
dc.description.abstract	This article examines the scientific foundations, clinical applications, and future challenges of pharmacogenomics , a discipline that investigates how genetic variations influence drug response in individuals. It explores the molecular principles underlying drug–gene interactions, mechanisms of variability in pharmacokinetics and pharmacodynamics, examples of gene-specific drug selection, advantages and limitations of individualized therapy, ethical issues, and implementation barriers in modern healthcare. The analysis highlights the growing significance of pharmacogenomic testing in optimizing therapeutic outcomes, minimizing adverse drug reactions, and advancing personalized medicine.	en_US
dc.language.iso	en_US	en_US
dc.publisher	O'zbekiston ( IQRO JURNALI )	en_US
dc.subject	pharmacogenomics, personalized medicine, genetic variability, drug response, precision therapy, biomarkers, pharmacokinetics, pharmacodynamics	en_US
dc.title	PHARMACOGENOMICS: INDIVIDUALIZED DRUG SELECTION	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
275-277.pdf		132.07 kB	Adobe PDF	View/Open

DSpace JSPUI